期刊文献+

不同时间窗冠状动脉介入治疗对急性心肌梗死患者血浆N-末端利钠肽前体水平的影响 被引量:4

Effect of percutaneous coronary intervention at different time windows on N-terminal pro-brain natriuretic peptide in patients with acute myocardial infarction
原文传递
导出
摘要 目的探讨不同时间窗内行经皮冠状动脉介入治疗(PCI)对急性心肌梗死患者(AMI)血浆N-末端利钠肽前体(NT-proBNP)水平、左室射血分数(LVEF)和预后的影响。方法 65例AMI患者按发病后至急诊PCI时间分组:A组(≤12h)29例,B组(12~24h)36例。分别比较两组患者术后心力衰竭发生情况及病死率、血浆NT-proBNP水平的动态变化情况和超声心动图测定的LVEF。结果 A组患者的心力衰竭发生率和病死率均较B组明显降低,但经χ2检验,差异均无统计学意义(P均>0.05)。两组患者入院即刻的血浆NT-proBNP水平比较,差异无统计学意义(P>0.05)。而经过急诊PCI治疗后,入院后24h和7d两个时间点,A组患者的血浆NT-proBNP水平均明显低于B组患者,差异均具有统计学意义(P均<0.05)。同时,AMI发生后30d时的超声心动图检查也显示,A组患者的LVEF明显高于B组患者,差异具有统计学意义(P<0.05)。结论急诊PCI是AMI最有效的治疗手段,接受PCI的治疗时间越早,AMI患者术后心肌受损程度越轻,心肌收缩功能改善也越明显。 Objective To investigate the effect of percutaneous coronary intervention (PCI) at different time windows on N-terminal pro-brain natriuretic peptide (NT-proBNP), left ventricular ejection fraction (LVEF), and prognosis in patients with acute myocardial infarction (AMI). Methods Sixty-five patients with AMI were divided into two groups according to the period from AMI attack to PCI treatment: group A (29 cases, P〈 12 h) and group B (36 cases, 12-24 h). Incidence and mortality of heart failure, NT-proBNP level, and LVEF were detected and compared. Results Compared with the group B, the incidence and mortality of heart failure in the group A were decreased apparently, but showed no significant difference via variance test (all P〉0.05). Observation comparing NT-proBNP levels revealed no significant difference between group A and B on admission (P〉0.05), whereas at 24 h and on 7th d after PCI, we observed a marked decrease in the group A (all P〈0.05). Meanwhile, LVEF in the group A were higher than the group B according to echoeardiogram examination on 30th d after AMI attack (P〈0.05). Conclusions PCI is an effective method in the treatment of AMI. The myocardial damage would be slighter and the myocardial performance would be markedly improved if the patients with AMI received PCI earlier.
出处 《中华危重症医学杂志(电子版)》 CAS 2011年第2期17-20,共4页 Chinese Journal of Critical Care Medicine:Electronic Edition
关键词 急性心肌梗死 时间窗 冠状动脉介入治疗 N-末端利钠肽前体 射血分数 Acute myocardial infarction Time window Percutaneous coronary intervention N-terminal pro-brain natriuretic peptide Ejection fraction
  • 相关文献

参考文献12

  • 1危小军,刘芳,廖伟,钟一鸣,谢东明,王小萍,廖祥中,谢东阳.经皮冠状动脉介入治疗老年急性心肌梗死最佳时间窗的临床研究[J].中华老年心脑血管病杂志,2007,9(4):278-278. 被引量:11
  • 2郭路芬,彭亚光,李庆祥,贺建华,赵冬,洪昭光.急性心肌梗死发病至就诊时间与预后的关系[J].中华心血管病杂志,2007,35(1):40-43. 被引量:76
  • 3马礼坤,余华,黄向阳,褚俊,冯克福,李世光,张晓红,邵正斌,丁晓梅,严激,顾统元.急性前壁心肌梗死后梗死相关血管延迟开通对晚期左室重构的影响[J].中华心血管病杂志,2005,33(4):328-331. 被引量:23
  • 4杨伟,陈万春,金惠根,刘宗军,汪蔚青,施佳,王东毅,方平.急性心肌梗死不同时间窗行直接冠状动脉介入治疗的疗效比较[J].上海医学,2005,28(1):49-52. 被引量:16
  • 5VanderheydenM,VrintsC,Verstreken S,et al.B-type natriuretic peptide as amarker ofheart failure:new insights from biochemistry and clinical implications. Biomark Med . 2010
  • 6Omland TJ,Persson A,Leong N,et al.N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation . 2002
  • 7Ndrepepa G,Braun S,Mehilli J,et al.N-terminal pro-brain natriuret-ic peptide on admission in patients with acute myocardial infarctionand correlation with scintigraphic infarct size,efficacy of reperfusionand prognosis. The American Journal of Cardiology . 2006
  • 8NALLAMOTHU BK,BRADLEY EH,KRUMHOLZ HM.Time totreatment in primary percutaneous coronary intervention. The New England Journal of Medicine . 2007
  • 9De Lemos JA,Hildebrandt P.Amino-terminal pro-B-type natriuretic peptides:testing in general populations. American Journal of Chinese Medicine . 2008
  • 10Winkler K,Wanner C,Drechsler C,et al.Changein N-termi-nal-pro-B-type-natriuretic-peptide and the risk of sud-den death,stroke,myocardial infarction,and all-cause mortal-ityin diabetic dialysis patients. European Heart Journal . 2008

二级参考文献29

  • 1Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA, 2000,283 : 2941-2947.
  • 2Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein Ⅱb/Ⅲa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med, 2001, 344. 1895-1903.
  • 3Petronio AS, Rovai D, Musumeci G,et al. Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty. Eur Heart J, 2003, 24:67-76.
  • 4Brodie BR, Stone GW, Morice MC, et al. Importance of time to reperfusion on outcome with primary coronary angioplasty for acute myocardial infarction (results from the Stent Primary Angioplasty in Myocardial Infarction Trial). Am J Cardiol,2001,88; 1085-1090.
  • 5Alhaddad IA, Kloner RA, Hakim I, et al. Benefits of late coronary artery reperfusion on infarct expansion progressively diminish over time: relation to viable islets of myocytes within the scar. Am Heart J, 1996,131:451-457.
  • 6Bertrand ME, Mcfadden EP. Late is perhaps not,., too late for primary PCI in acute myocardial infarction. Eur Heart J,2002,23 : 1146-1148.
  • 7Da FY, Chen XL, Drzewiecki G. et al. Hypervolamia improves global and local function and efficiency in postischaemic myocardium. Clin Exp Pharmacol Physiol, 2001,28 : 630-636.
  • 8Wang X, Kendem J, Du FY. Et al. Effect of volume loading on reperfused myocardium following 2-hour ischemia. The FASEB Journal-Experimental Biology 2001: An annual meeting of Professional Research Scientists. Orlando, Florida.2001 : part Ⅰ-A464 (abstract).
  • 9Srinivas VS, Vakili BA, Brown DL. Comparison of in-hospital outcomes following early and delayed angioplasty for acute myocardial infarction. J Invasive Cardiol, 2002, 14 : 746-750.
  • 10Brodie BR, Stuckey TD, Muncy DB, et al. Importance of time-to-reperfusion in patients with acute myocardial infarction with and without cardiogenic shock treated with primary percutaneous coronary intervention. Am Heart J, 2003, 145:708-715.

共引文献118

同被引文献36

  • 1Chan W, Stub D, Clark D J, et al. Usefulness of t- ransient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention[J]. Am J Cardiol, 2012, 109(4): 478- 485.
  • 2Ikata J, Wakatsuki T, Oishi Y, et al. Leukocyte counts and concentrations of sluble adhesion molecules as predictors of coronary atherosclerosis[J]. Coron Artery Dis, 2000, 11 (6): 445-449.
  • 3Iliodromitis EK, Andreadou I, Markantonis-Kyroudis S, et al. The effects of tirofiban on peripheral markers of oxidative stress and endothelial dysfunc- tion in patients with acute coronary syndromes [J]. Thromb Res, 2007, 119 (2): 167-174.
  • 4Boos CJ, Balakrishnan B, Jessani S, et al. Effects of percutaneous coronary intervention on peripheral venous blood circulating endothelial cells and plasma indices of endothelial damage/dysflinction [J]. Chest, 2007, 132 (6): 1920-1926.
  • 5Chew DP, Bhatt DL, Robbins MA, et al. Incremen- tal prognostic value of elevated baseline C-reactive protein among established markers of risk in percuta- neous coronary intervention [J]. Circulation, 2001, 104 (9): 992-997.
  • 6Saleh N, Svane B, Jensen J, et al. Stent implanta- tion, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels af- ter percutaneous coronary intervention in patients with stable angina pectoris [J]. Am Heart J, 2005, 149 (5): 876-882.
  • 7Azar RR, McKay RG, Kiernan FJ, et al. Coronary angioplasty induce a systemic inflammatory response [J]. Am J Cardiol, 1997, 80 (11): 1476-1478.
  • 8Staudacher DL,Langner O,Biever P,et al.Unprotected left main percutaneous coronary intervention in acute coronary syndromes with extracorporeal life support backup. Scientifica (Cairo) . 2015
  • 9Sugiyama T,Hasegawa K,Kobayashi Y,et al.Differential Time Trends of Outcomes and Costs of Care for Acute Myocardial Infarction Hospitalizations by ST Elevation and Type of Intervention in the United States,2001-2011. Journal of the American Pharmaceutical Association . 2015
  • 10Bernhard Witzenbichler,Akiko Maehara,Giora Weisz,Franz-Josef Neumann,Michael J. Rinaldi,D. Christopher Metzger,Timothy D. Henry,David A. Cox,Peter L. Duffy,Bruce R. Brodie,Thomas D. Stuckey,Ernest L. Mazzaferri,Ke Xu,Helen Parise,Roxana Mehran,Gary S. Mintz,Gregg W. Stone.??Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Study(J)Circulation . 2014 (4)

引证文献4

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部